ARCHIVES

Recombinant TSH Avoids Need To Stop Replacement Therapy

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

MD Anderson President Ronald DePinho: “Some of the Feedback was Humbling”

March 29, 2013

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

January 4, 2002

Scientific Community Rallies To Support DeVita; Immediate Suspension Of Straus’ Grant Considered

June 12, 1981

Halterman, Mahoney And Their Grants Go To DCT, Along With Some Program Projects

March 17, 1978

TGen and George Mason Form Precision Medicine Alliance

May 16, 2014

NTP Board Approves Concept Of Human Cell Assay For Genetic Toxicity

March 25, 1983